Answer
Hepatic dysfunction, primarily mild, transient elevations in aminotransferases and total bilirubin, has been reported during treatment with Farydak (panobinostat).
Sources for this answer
- Farydak 10mg hard capsulespharmaand GmbH · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked